Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it

Affiliations

• ¹ Department of Paediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
• ² Department of Pediatric Oncology, Prinses Maxima Centrum, Utrecht, The Netherlands.
• ³ Department of Pediatric Oncology and Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, Sweden.
• ⁴ Pediatric Hematology and Oncology, Geneva University Hospital, Geneva, Switzerland.
• ⁵ Paediatric Oncology, Our Lady's Children's Hospital, Dublin, Ireland.
• ⁶ Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
• ⁷ Department of Pediatric Audiology, Oregon Health and Science University, Portland, Oregon, USA.
• ⁸ Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa.
• ⁹ Department of Pediatric Oncology, Oregon Health and Science University, Portland, Oregon, USA.
• ¹⁰ Department of Statistics, International Breast Cancer Study Group, Bern, Switzerland.
• ¹¹ Children's Cancer and Blood Disorders Center, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
• ¹² Department of Pediatric Oncology, Agia Sofia Children's Hospital, Athens, Greece.
• ¹³ Department of Paediatric Audiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
• ¹⁴ Radiation Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
• ¹⁵ Division of Pediatric Neuro-Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
• ¹⁶ Children's Cancer Centre and Department of Paediatric Oncology, Royal Children's Hospital, Melbourne, Victoria, Australia.